Janssen’s TREMFYA One-Press Patient-controlled Injector for Adults with Plaque Psoriasis Receives FDA Approval

TREMFYA One Press
Janssen Pharmaceutical’s TREMFYA® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-severe plaque psoriasis received FDA approval. TREMFYA is the first FDA-approved medication of its kind to offer the One-Press […]
To access this page, watch the live stream and videos on-demand, you must purchase the Free Subscription, Premium Subscription or Premium Subscription (6 months, special rate).